Good news, if you don't get to here you go nowhere...
This is very interesting....
FDA have agreed to test 90mg efti dosing in combination with paclitaxel driven predominantly by the excellent
safety profile of the AIPAC Phase IIb trial, along with the FDA’s Project Optimus initiative in oncology.
Presumably, the higher the dose the quicker the response......shows the unmet need importance in regard
to FDA discussions...seems like upping the dose was an immutep iniative.....good signs here..
Ann: Update on MBC trial design following successful FDA meeting, page-4
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
32.3¢ |
Change
0.008(2.38%) |
Mkt cap ! $469.0M | |||
| Open | High | Low | Value | Volume |
| 31.5¢ | 32.5¢ | 31.0¢ | $811.5K | 2.553M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 17 | 132108 | 32.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 32.5¢ | 420431 | 37 |
View Market Depth
| Last trade - 14.51pm 19/11/2024 (20 minute delay) ? |
| IMM (ASX) Chart |